Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM

Standard Dose
500MCG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 217066 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength POWDER;INTRAVENOUS - 500MCG/VIAL Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2023-03-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 217066 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength POWDER;INTRAVENOUS - 500MCG/VIAL Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2023-03-24 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.